Latest News

Battelle Develops System to Decontaminate Personal Protective Equipment to Meet Growing Demand During COVID-19 Crisis

COLUMBUS, Ohio–(BUSINESS WIRE)–Battelle announced today that it has received Food and Drug Administration (FDA) Emergency Use Authorization (EUA) to support front-line healthcare workers as they face critical shortages of personal protective equipment (PPE). The Battelle CCDS Critical Care Decontamination System™ is now operating at Battelle’s West Jefferson, Ohio facility under the EUA and is capable of decontaminating up to 80,000 respirator masks per system each day using concentrated, vap

Source link

Related posts

Hospitals Participating in 340B Program Offer More Low-Profit Services, Uncompensated Care


NLM Technical Bulletin, Sep-Oct 2018, September 2018 SNOMED CT US Edition Available for Download


State Policy Approaches to Incorporating Doula Services into Maternal Care


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy